Triglyceride-rich lipoproteins and residual CV risk
This lecture by Erik Stroes is part of a series titled "Targeting TG-rich remnant lipoproteins: Review of new insights and clinical opportunities".
This program has been designed to educate physicians and other healthcare professionals with an interest in CV risk on lipid-associated residual risk beyond LDL-c and provide an update of novel findings in basic and clinical science with regard to the association of triglyceride-rich remnant lipoproteins and CV risk. In addition, guidance will be given how to use findings from studies on triglyceride-rich lipoproteins in the treatment of patients in clinical practice.
Prof. Erik Stroes, MD, PhD - Professor of Vascular Medicine, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
Funding for this educational program was provided by an unrestricted educational grant received from Pfizer.